Brady Corp. A Stock
Brady Corp. A Stock
The price for the Brady Corp. A stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.590%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Brady Corp. A stock is not clear.
With a target price of 89 € there is a slightly positive potential of 5.33% for Brady Corp. A compared to the current price of 84.5 €.
Pros and Cons of Brady Corp. A in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Brady Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Brady Corp. A | -0.590% | -2.924% | 3.750% | 36.066% | 22.059% | 76.596% | 83.628% |
| Fti Consulting | -0.740% | -3.571% | 8.000% | -5.594% | -7.534% | -19.162% | 12.500% |
| ABM Industries Inc. | 0.470% | -1.860% | 9.326% | 5.500% | 16.575% | 2.427% | 7.653% |
| Exponent Inc. | -1.260% | 9.848% | 11.249% | 0.440% | -1.950% | -26.876% | -35.675% |
Comments
Brady (BRC) was upgraded by Sidoti from "neutral" to "buy". They now have a $103.00 price target on the stock.
Show more
Ratings data for BRC provided by MarketBeat
Brady (NYSE:BRC) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BRC provided by MarketBeat
Brady Co. (NYSE: BRC) was upgraded by analysts at Sidoti to a "strong-buy" rating.
Show more
Ratings data for BRC provided by MarketBeat
News
Zebra Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Zebra Technologies Corporation? Here are five stocks we like better.
- Record Q2 performance: Sales rose 20.4% year over year to more than $1.5 billion, while adjusted
PHINIA Q2 Earnings Call Highlights
Key Points
- Interested in PHINIA Inc.? Here are five stocks we like better.
- Second-quarter results improved: Revenue rose 5.6% year over year to $940 million, while adjusted EBITDA increased to
Medpace Q2 Earnings Call Highlights
Key Points
- Interested in Medpace Holdings, Inc.? Here are five stocks we like better.
- Medpace posted strong Q2 results, with revenue up 17.2% to $707.3 million and diluted EPS rising to $4.25